1-(4-(4-(((2R,4S)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-3,4-dihydropyrazin-1(2H)-yl)ethanone; 2,3-Dehydro Ketoconazole; rel-1-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-3,4-dihydro-1(2H)-pyrazinyl]ethanone; rel-1-Acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1,2,3,4-tetrahydropyrazine; R 049223; Ketoconazole Impurity A; Ketoconazole EP Impurity A
Ketoconazole EP Impurity A is a fully characterized chemical compound used as a reference standard of API Ketoconazole. The standard offered is compliant with regulatory guidelines. Ketoconazole EP Impurity A is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 254912-63-5
